These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 37973628)

  • 1. The new European Society of Cardiology guideline for the management of cardiomyopathies: key messages for cardiac electrophysiologists.
    Korthals D; Eckardt L
    Herzschrittmacherther Elektrophysiol; 2023 Dec; 34(4):311-323. PubMed ID: 37973628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiomyopathies: a practical approach to the assessment and management of patients and their families].
    Hiestand R; Gruner C
    Ther Umsch; 2024 Apr; 81(2):60-66. PubMed ID: 38780212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of cardiomyopathies : New ESC guidelines 2023].
    Pavo N; Hengstenberg C
    Herz; 2024 Feb; 49(1):22-32. PubMed ID: 38051386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy.
    Goff ZD; Calkins H
    Prog Cardiovasc Dis; 2019; 62(3):217-226. PubMed ID: 31004608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects.
    Könemann H; Dagres N; Merino JL; Sticherling C; Zeppenfeld K; Tfelt-Hansen J; Eckardt L
    Europace; 2023 May; 25(5):. PubMed ID: 37102266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2023 ESC Guidelines for the management of cardiomyopathies.
    Arbelo E; Protonotarios A; Gimeno JR; Arbustini E; Barriales-Villa R; Basso C; Bezzina CR; Biagini E; Blom NA; de Boer RA; De Winter T; Elliott PM; Flather M; Garcia-Pavia P; Haugaa KH; Ingles J; Jurcut RO; Klaassen S; Limongelli G; Loeys B; Mogensen J; Olivotto I; Pantazis A; Sharma S; Van Tintelen JP; Ware JS; Kaski JP;
    Eur Heart J; 2023 Oct; 44(37):3503-3626. PubMed ID: 37622657
    [No Abstract]   [Full Text] [Related]  

  • 7. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies.
    Charron P; Elliott PM; Gimeno JR; Caforio ALP; Kaski JP; Tavazzi L; Tendera M; Maupain C; Laroche C; Rubis P; Jurcut R; Calò L; Heliö TM; Sinagra G; Zdravkovic M; Kavoliuniene A; Felix SB; Grzybowski J; Losi MA; Asselbergs FW; García-Pinilla JM; Salazar-Mendiguchia J; Mizia-Stec K; Maggioni AP;
    Eur Heart J; 2018 May; 39(20):1784-1793. PubMed ID: 29378019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.
    Maron BJ; Rowin EJ; Maron MS
    Circ Res; 2019 Aug; 125(4):370-378. PubMed ID: 31518168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].
    Pankuweit S; Richter A; Ruppert V; Maisch B
    Herz; 2009 Feb; 34(1):55-62. PubMed ID: 19214409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Ommen SR; Mital S; Burke MA; Day SM; Deswal A; Elliott P; Evanovich LL; Hung J; Joglar JA; Kantor P; Kimmelstiel C; Kittleson M; Link MS; Maron MS; Martinez MW; Miyake CY; Schaff HV; Semsarian C; Sorajja P
    J Am Coll Cardiol; 2020 Dec; 76(25):3022-3055. PubMed ID: 33229115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study.
    Rowin EJ; Maron MS; Adler A; Albano AJ; Varnava AM; Spears D; Marsy D; Heitner SB; Cohen E; Leong KMW; Winters SL; Martinez MW; Koethe BC; Rakowski H; Maron BJ
    Heart Rhythm; 2022 May; 19(5):782-789. PubMed ID: 34933112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies.
    Polovina M; Tschöpe C; Rosano G; Metra M; Crea F; Mullens W; Bauersachs J; Sliwa K; de Boer RA; Farmakis D; Thum T; Corrado D; Bayes-Genis A; Bozkurt B; Filippatos G; Keren A; Skouri H; Moura B; Volterrani M; Abdelhamid M; Ašanin M; Krljanac G; Tomić M; Savarese G; Adamo M; Lopatin Y; Chioncel O; Coats AJS; Seferović PM
    Eur J Heart Fail; 2023 Dec; 25(12):2144-2163. PubMed ID: 37905371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ESC guideline 2022: management of ventricular arrhythmias in clinical practice].
    Könemann H; Frommeyer G; Eckardt L
    Dtsch Med Wochenschr; 2023 Mar; 148(6):325-330. PubMed ID: 36878232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter-defibrillator using the 2014 European Society of Cardiology guidelines.
    Nakano M; Kondo Y; Nakano M; Kajiyama T; Miyazawa K; Hayashi T; Ito R; Takahira H; Kobayashi Y
    Heart Vessels; 2021 Jan; 36(1):99-104. PubMed ID: 32666207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
    Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ;
    Eur Heart J; 2015 Nov; 36(41):2793-2867. PubMed ID: 26320108
    [No Abstract]   [Full Text] [Related]  

  • 16. [Arrhythmias in cardiomyopathies].
    Kaneko Y; Kurabayashi M
    Nihon Rinsho; 2002 Jul; 60(7):1434-9. PubMed ID: 12136626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy.
    Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L
    Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy.
    Goff ZD; Calkins H
    Prog Cardiovasc Dis; 2019; 62(3):212-216. PubMed ID: 31004609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Updated ESC guideline: innovations for the treatment of ventricular arrhythmias and recommendations for prevention of sudden cardiac death].
    Eckardt L; Deneke T
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):288-94. PubMed ID: 27581243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.